Vidhi Specialty Food FY26 Net Profit Rises 10.80%; Capex Plans and New Product Lines in Focus

4 min read     Updated on 19 May 2026, 03:28 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Vidhi Specialty Food Ingredients Limited reported FY26 net profit of INR49.15 crores, up 10.80% YoY, with EBITDA improving to INR78 crores and margins expanding to 20.52% despite flat revenues of INR380 crores. The company outlined capex of INR75–85 crores for new high-margin product lines at Dahej, with commissioning expected in the middle of FY28, while its CoatIcon pharma coating range advances through customer qualification stages.

powered bylight_fuzz_icon
40043086

*this image is generated using AI for illustrative purposes only.

Vidhi Specialty Food Ingredients Limited held its Q4 and FY26 Earnings Conference Call on May 14, 2026, with Chairman and Managing Director Bipin Manek, Joint Managing Director Mihir Manek, and Chief Financial Officer Mitesh Manek presenting the company's audited financial results for the year ended March 31, 2026. The management highlighted resilient performance despite significant global economic uncertainty, geopolitical tensions, tariff pressures, and a slowdown in demand across several international markets.

Financial Performance

The company reported revenue from operations of INR380 crores for FY26, compared to INR382.30 crores in FY25. Despite subdued demand in certain international markets during the first half of the year, disciplined cost management and product mix optimization enabled the company to deliver strong profitability. The following table summarises key financial metrics:

Metric FY26 FY25
Revenue from Operations INR380 crores INR382.30 crores
EBITDA INR78 crores INR68 crores
EBITDA Margin 20.52% 17.91%
Profit Before Tax INR65.97 crores INR60.16 crores
Net Profit INR49.15 crores INR44.35 crores
Net Profit Margin 12.93% 11.66%
Operating Profit Margin 21.01% 18.75%
Profit Before Tax Margin 17.36% 16.10%

Net profit grew 10.80% year-on-year to INR49.15 crores, while EBITDA margins expanded from 17.91% to 20.52%, supported by better realizations, increased contribution from specialty and high-margin products, improved manufacturing efficiencies, and tighter cost management. The CFO noted that manufacturing sales for FY26 stood at INR330 crores, with the effective EBITDA margin on manufactured sales close to 24%–25%.

Balance Sheet and Key Ratios

The company maintained a strong and conservative balance sheet. The debt-to-equity ratio remained low at 0.28%, reflecting prudent fiscal management. Key operational and return ratios are presented below:

Ratio FY26 FY25
Debt-to-Equity Ratio 0.28%
Return on Capital Employed 20.90% 20.17%
Return on Equity 14.94% 14.92%
Debtors Turnover Ratio 2.66% 2.91%
Inventory Turnover Ratio 4.70% 4.99%
Current Ratio 3.91% 2.92%
Interest Coverage Ratio 16.75% 28.27%

The CFO noted that the decline in the interest coverage ratio was attributable to the withdrawal of the subvention scheme on export finance by the Indian government as of December 2025, which led to a slight increase in finance costs.

Operational Highlights and Export Markets

Management stated that demand conditions remained subdued in certain international markets during the first half of FY26 but improved subsequently. The company expects full utilization of both its Dahej and Roha facilities in the current financial year. On export markets, the management clarified that exports to North America (comprising the U.S., Canada, and Mexico) account for 19% of total exports. Mihir Manek noted that while the U.S. market has stabilised following tariff-related disruptions, additional growth is expected from emerging markets as geopolitical conditions ease. Customer inventory levels in the U.S. had reduced by approximately 50% during the period of elevated tariffs as customers drew down existing stocks. The management also addressed concerns around synthetic food color regulations in the U.S., clarifying that all exported color ranges are approved by the U.S. FDA and that each batch undergoes testing at the FDA's Washington laboratory before being cleared for use.

Strategic Initiatives and Capital Expenditure

The company is advancing its CoatIcon range of tablet coating systems, currently in aggressive sampling and customer qualification stages with several pharmaceutical companies in India and international markets. The typical customer approval cycle for this product is approximately 6 months due to stability testing requirements. The contribution of high-value, high-margin products to the total product portfolio currently stands at approximately 5%, with management expecting this to rise to 10%–12% or higher in FY27. Key capital expenditure details are summarised below:

Initiative Details
CoatIcon Pharma Coating (Scale-up) INR5 crores to INR12 crores
New Product Lines – Phase 1 Capex INR75 crores to INR85 crores
Expected Capex Deployment Largely in FY27
Commissioning Timeline Middle of FY28 (18 months)
Expected Phase 1 Revenue Potential INR125 crores to INR150 crores
Facility Dahej

The new product lines under development are described as having a very high margin profile with thin to negligible competition. The company has two R&D facilities on the outskirts of Mumbai, employing in excess of 60 dedicated chemists, and has invested in excess of INR4.5 crores to INR5 crores in analytical equipment at these facilities. Management also noted a one-off increase in other expenses during the quarter, partly attributable to R&D costs and U.S. FDA certification costs of $1 per kilogram, which are to be passed on to customers upon sale of the relevant products.

Historical Stock Returns for Vidhi Specialty Food Ingredients

1 Day5 Days1 Month6 Months1 Year5 Years
+0.36%+1.14%-8.52%-22.01%-34.45%+39.41%

How quickly could Vidhi Specialty's new high-margin product lines ramp up to meaningful revenue contribution beyond the projected INR125–150 crores, and what competitive risks could emerge once these 'negligible competition' products gain market visibility?

Given that North America accounts for 19% of exports and U.S. customer inventory levels dropped ~50% during tariff disruptions, how vulnerable is Vidhi's revenue trajectory to any re-escalation of U.S.-India trade tensions or new tariff regimes?

With the CoatIcon pharma coating range currently at only 5% of the portfolio and targeting 10–12% by FY27, what is the realistic addressable market size in India and internationally, and which competing tablet coating suppliers pose the greatest threat to customer adoption?

Vidhi Specialty Food Ingredients
View Company Insights
View All News
like20
dislike

Vidhi Specialty Food Ingredients Submits Q4FY26 Compliance Certificate to Stock Exchanges

1 min read     Updated on 08 Apr 2026, 04:33 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Vidhi Specialty Food Ingredients Limited filed its compliance certificate under SEBI Regulation 74(5) for Q4FY26 on April 08, 2026. The certificate from registrar MUFG Intime India confirms proper handling of dematerialized securities during the quarter ended March 31, 2026. The filing was submitted to both BSE and NSE, fulfilling regulatory requirements for securities management and maintaining transparency in depository operations.

powered bylight_fuzz_icon
37191839

*this image is generated using AI for illustrative purposes only.

Vidhi Specialty Food Ingredients Limited has submitted its mandatory compliance certificate to stock exchanges for the quarter and financial year ended March 31, 2026. The filing demonstrates the company's adherence to regulatory requirements for securities management and depository operations.

Regulatory Compliance Filing

The company filed the compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 on April 08, 2026. The certificate was submitted to both BSE Limited and National Stock Exchange of India Limited, where the company's shares are listed.

Exchange Details: Information
BSE Script Code: 531717
NSE Trading Symbol: VIDHIING
Filing Date: April 08, 2026
Reporting Period: Quarter and FY ended March 31, 2026

Registrar Confirmation

The compliance certificate was issued by MUFG Intime India Pvt. Ltd. (formerly known as Link Intime), which serves as the company's Registrar and Share Transfer Agent. The certificate, dated April 3, 2026, was signed by Ashok Shetty, Sr. Vice President-Corporate Registry.

MUFG Intime confirmed that securities received from depository participants for dematerialization during the quarter ended March 31, 2026 were properly processed. The registrar verified that all security certificates received for dematerialization were confirmed or rejected within prescribed timelines and that the depositories' names were appropriately substituted in the register of members.

Corporate Governance

The filing was signed by Anupam J Vyas, Company Secretary and Compliance Officer of Vidhi Specialty Food Ingredients Limited. The digital signature was applied on April 08, 2026, ensuring proper authorization and documentation of the regulatory submission.

Company Operations: Details
Mumbai Office: E/27/28/29, Commerce Centre, 78, Tardeo Road
Manufacturing Units: Roha (Maharashtra) and Dahej SEZ (Gujarat)
Business Focus: Specialty food ingredients
CIN: L24110MH1994PLC076156

This compliance certificate filing represents a routine regulatory requirement that publicly listed companies must fulfill to maintain transparency in their securities management and depository operations. The submission ensures that all stakeholders are informed about the proper handling of dematerialized securities during the reporting period.

Historical Stock Returns for Vidhi Specialty Food Ingredients

1 Day5 Days1 Month6 Months1 Year5 Years
+0.36%+1.14%-8.52%-22.01%-34.45%+39.41%

How might Vidhi Specialty Food Ingredients' expansion plans for their manufacturing units in Maharashtra and Gujarat impact their market position in FY 2027?

What potential growth opportunities could emerge for specialty food ingredient companies following recent regulatory compliance improvements in the Indian market?

Will the company's partnership with MUFG Intime as registrar influence their future capital market activities or fundraising strategies?

Vidhi Specialty Food Ingredients
View Company Insights
View All News
like17
dislike

More News on Vidhi Specialty Food Ingredients

1 Year Returns:-34.45%